国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
3种抗菌药治疗老年性肺炎的药物经济学评价
Pharmacoeconomic Evaluation of Three Kinds of Antibacterial in the Treatment of Senile Pneumonia
  
DOI:
中文关键词:  抗菌药 老年性肺炎 药物经济学 成本-效果分析
英文关键词:Antibacterial,Senile pneumonia,Pharmacoeconomics,Cost effectiveness analysis
基金项目:
常翠  $2  杨宏图  宁德俄  董淳
[1]深圳市人民医院暨南大学第二附属医院药学部,广东深圳518020 [2]山西医科大学附属医院
摘要点击次数: 1586
全文下载次数: 128
中文摘要:
      目的:评价3种抗菌药治疗老年性肺炎的疗效及经济效果。方法:选择372例老年性肺炎患者,随机分为3组,分别给予头孢曲松钠、左氧氟沙星、洛关沙星治疗,观察各组疗效并运用药物经济学方法进行分析。结果:3组治疗有效率分别为80.65%、87.1%、72.58%;不良反应发生率分别为7.65%、6.35%、13.81%。平均成本一效果比分别为6528、10392、11196。结论:药物经济学分析结果为头孢曲松钠优于左氧氟沙星,优于洛关沙星。
英文摘要:
      Objective: To evaluate the therapeutic efficacy and pharmacoeconomic effect of three kinds of anti bacterial in the treatment of senile pneumonia.Method: 372 senile patients with pneumonia were randomly divided into three groups, They were given ceftriaxone,levofloxacin and lomefloxacin respectively. Their therapeutic effects were observed and pharmacoeconomic analysis was made.Result: The effective rates of the three groups were 80.65% , 87.1% and 72.58% ,while the adverse drug reaction rates were 7.65% , 6.35% and 13.81% , the cost effectiveness ratios were 6 528,10 392 and 11 196 respectively.Conclusion: The pharmacoeconomic analysis indicated that ceftriaxone was superior to both levofloxacin and lomefloxacin.
查看全文  查看/发表评论  下载PDF阅读器
关闭